HomeClinical TopicsFDA approves injection for type 2 diabetes

FDA approves injection for type 2 diabetes

On July 28, the Food and Drug Administration (FDA) approved Adlyxin (lixisenatide), a once-daily injection to improve glycemic control, along with diet and exercise, in adults with type 2 diabetes. Read more

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Recent Content